Back to User profile » Dr Dan Luo
Paper published by Dr Dan Luo:
Original Research
Post-Marketing Safety Concerns with Efgartigimod alfa: A Pharmacovigilance Analysis Based on the Food and Drug Administration Adverse Event Reporting System Database
Huang J, Ye H, Lin J, Luo D, Huang P, Zheng X
Clinical Epidemiology 2025, 17:765-778
Published Date: 16 September 2025